Mesalamine Enemas May Be Helpful in Pediatric Ulcerative Colitis Mesalamine Enemas May Be Helpful in Pediatric Ulcerative Colitis
Following failure of high-dose oral mesalamine (5-aminosalicylic acid), topical enemas containing the agent may be effective in many children with mild to moderate ulcerative colitis (UC), according to Israeli and Finnish researchers.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - April 20, 2017 Category: Surgery Tags: Pediatrics News Source Type: news
Budesonide Multi-matrix Induces Endoscopic Remission in Refractory UC Budesonide Multi-matrix Induces Endoscopic Remission in Refractory UC
Budesonide multi-matrix induces remission in patients with mild to moderate mesalamine-refractory ulcerative colitis (UC), researchers report.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - March 24, 2017 Category: Surgery Tags: Gastroenterology News Source Type: news
Rowasa (Mesalamine Rectal Suspension Enema) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 24, 2017 Category: Drugs & Pharmacology Source Type: news
U-M researchers discover what makes drug for ulcerative colitis tick
(University of Michigan) For approximately 70 years, physicians have used a medication containing the active agent mesalamine to treat ulcerative colitis, but little was known about how the drug targeted the inflammatory bowel disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 23, 2017 Category: Global & Universal Source Type: news
Lialda (Mesalamine) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 18, 2017 Category: Drugs & Pharmacology Source Type: news
Pentasa (Mesalamine) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 13, 2017 Category: Drugs & Pharmacology Source Type: news
Asacol (Mesalamine Delayed-Release Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 13, 2017 Category: Drugs & Pharmacology Source Type: news
Apriso (Mesalamine Extended-Release Capsules) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 3, 2017 Category: Drugs & Pharmacology Source Type: news
Canasa (Mesalamine) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 16, 2016 Category: Drugs & Pharmacology Source Type: news
Allergan Announces Settlement of a DELZICOL(R) (mesalamine) Patent Litigation
DUBLIN, Dec. 2, 2016 -- (Healthcare Sales & Marketing Network) -- Allergan plc (AGN), a leading global pharmaceutical company, and its subsidiaries today announced that they, along with Qualicaps Co., Ltd., have reached a settlement regarding their litiga... Biopharmaceuticals, Litigation Allergan, Zydus Pharmaceuticals, DELZICOL, mesalamine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 2, 2016 Category: Pharmaceuticals Source Type: news
Pharma ’s Nutritional Value
With previous senior management roles at both Novartis and Boehringer Ingelheim, Greg Behar is a pharma man – or he was. In 2014, he became CEO ofNestl é Health Science, a company whose mission is to place nutrition into a key role in the management of people ’s health.While Nestl é itself is best-known as a manufacturer of confectionary, Nestlé Health Science occupies the space between nutrition and pharma – science-based, personalized nutritional therapies. Behar, who will be speaking ateyeforpharma Barcelona 2017, says the company offers great opportunities to develop “amazing breakthrough approaches to treat...
Source: EyeForPharma - October 4, 2016 Category: Pharmaceuticals Authors: Adam Hill Source Type: news
Shire Wins Patent Trial Against Watson Concerning LIALDA(R)
LIALDA Patent Upheld and Extends through June 8, 2020
LEXINGTON, Massachusetts, March 29, 2016 -- (Healthcare Sales & Marketing Network) -- Shire plc (LSE: SHP, NASDAQ: SHPG) and its subsidiary, Shire Development LLC, announced today that the United St... Biopharmaceuticals, Generics, LitigationShire plc, LIALDA, mesalamine, Watson Pharmaceuticals, ulcerative colitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 29, 2016 Category: Pharmaceuticals Source Type: news
Shire gets favorable ruling against Allergan in Lialda patent case
(Reuters) - A U.S. district court on Monday ruled in favor of Shire Plc, preventing Allergan Plc from selling generic versions of Lialda, the ulcerative colitis drug, in the United States until 2020. (Source: Reuters: Health)
Source: Reuters: Health - March 28, 2016 Category: Consumer Health News Tags: healthNews Source Type: news
mesalamine, Lialda
Title: mesalamine, LialdaCategory: MedicationsCreated: 12/10/2008 12:00:00 AMLast Editorial Review: 1/22/2016 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - January 22, 2016 Category: Nutrition Source Type: news
Anti-TNF Best at Preventing Postsurgery Relapse in Crohn's Anti-TNF Best at Preventing Postsurgery Relapse in Crohn's
Anti-TNF appears to be more effective than mesalamine, antibiotics, and budesonide. Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - January 6, 2015 Category: Gastroenterology Tags: Gastroenterology News Source Type: news
